文献速递泌尿系感染

算法提升门诊无发热复杂性膀胱炎经验性抗菌选择:尿路状态与居住地重要性

Algorithms to Enhance Empiric Antimicrobial Choice for Outpatients With Afebrile Complicated Cystitis Reflects Importance of Status of the Urinary Tract and Patient Place of Residence.
PubMed 文献 · Urology · 2020-09-01

该回顾性单中心横断面研究纳入2012至2018年2891例门诊无发热复杂性膀胱炎患者,分析2012-2016年数据确定耐药预测因素并构建抗菌治疗算法,在2017-2018年数据验证。结果显示居住地(邮编)、尿路状态(复杂vs非复杂)和既往耐药是影响耐药的一致预测因素,所建算法优于实际医生选择和既往非复杂性膀胱炎算法。

要点

  • 居住地邮编、尿路复杂状态和既往耐药是耐药一致预测因素。
  • 复杂性膀胱炎算法优于实际医生选择和既往非复杂性膀胱炎算法。
  • 算法可辅助门诊无发热复杂性膀胱炎的经验性抗菌选择。

核心结论

  • 复杂性膀胱炎治疗算法依赖患者居住地邮编、宿主尿路状态(复杂或非复杂)和既往尿培养耐药数据。
  • 使用该算法(不考虑尿路病原体)结果优于实际医生选择和既往非复杂性膀胱炎算法,可帮助指导经验性抗菌选择。

研究设计与样本

  • 回顾性、单中心、横断面研究,纳入2012至2018年2891例诊断为无发热复杂性膀胱炎的门诊患者。
  • 对确认尿路感染且有抗菌药物敏感性的患者,使用2012-2016年数据进行单因素分析和多因素回归模型确定耐药预测因素,并构建抗菌选择算法,在2017-2018年数据上测试。

主要发现

  • 无发热复杂性膀胱炎门诊患者中,对甲氧苄啶-磺胺甲噁唑、环丙沙星、呋喃妥因、第一代头孢菌素和第三代头孢菌素的总体耐药率分别为25.6%、19.5%、19.1%、15.0%和6.9%。
  • 影响所有5种抗菌药物耐药的一致预测因素为患者居住地(邮编)、宿主尿路状态(复杂vs非复杂)和既往对该抗菌药物的耐药。

关键数值与推荐

  • 总体耐药率:甲氧苄啶-磺胺甲噁唑25.6%,环丙沙星19.5%,呋喃妥因19.1%,第一代头孢菌素15.0%,第三代头孢菌素6.9%。
  • 耐药预测因素包括居住地邮编、尿路状态(复杂vs非复杂)和既往耐药。

临床怎么用

  • 门诊无发热复杂性膀胱炎经验性抗菌选择可参考基于居住地邮编、尿路复杂状态和既往尿培养耐药数据的治疗算法。
  • 该算法优于实际医生选择和既往非复杂性膀胱炎算法,可辅助临床决策。

局限性

  • 回顾性单中心研究,结果可能受机构实践和地区耐药模式影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine predictive factors for antimicrobial resistance patterns and to develop an antimicrobial treatment algorithm for afebrile outpatients presenting with complicated cystitis. MATERIALS AND METHODS: We performed a retrospective, single-center, cross-sectional study of 2,891 outpatients with a diagnosed afebrile complicated cystitis from 2012 to 2018. For patients with confirmed urinary tract infection and antimicrobial sensitivities, univariate analyses and multivariable regression models were used to determine odds ratios for predicting resistance to trimethoprim-sulfamethoxazole, ciprofloxacin, nitrofurantoin, first-generation cephalosporin, and third-generation cephalosporin for the 2012-2016 data. Antimicrobial choice algorithms were created using 2012-2016 results and tested on 2017-2018 data. RESULTS: For afebrile outpatients presenting with complicated cystitis, overall prevalence of resistance for trimethoprim-sulfamethoxazole, ciprofloxacin, nitrofurantoin, first-generation cephalosporin, and third-generation cephalosporin was 25.6%, 19.5%, 19.1%, 15.0%, and 6.9%, respectively. Consistent predictive factors influencing resistance to all 5 antimicrobials were patient place of residence (ZIP code), status of host urinary tract (complicated vs uncomplicated), and prior resistance to the antimicrobial. Resulting treatment algorithm for complicated cystitis (whether or not prior microbiologic data was available) outperformed real-life provider choice and our previously published algorithm for uncomplicated cystitis. CONCLUSION: Treatment algorithms for urinary tract infections are dependent on patient place of residence (ZIP code), status of the host urinary tract (complicated or uncomplicated), and prior urine culture resistance data. When using our complicated cystitis treatment algorithm regardless of uropathogen, our results outperformed real-life scenario provider choice and our prior published algorithm for uncomplicated cystitis, which can help guide empiric antimicrobial choice.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Cooley LF, Cohen JE, Chen L, et al. Algorithms to Enhance Empiric Antimicrobial Choice for Outpatients With Afebrile Complicated Cystitis Reflects Importance of Status of the Urinary Tract and Patient Place of Residence. Urology. 2020. PMID: 32882305. doi:10.1016/j.urology.2020.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。